Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) Stock Price: $188.41+4.88 (+2.66%)

The total return cagr for Danaher Corporation (DHR) stock is -4.76% over the past 12 months. The 3 year average growth rate is -2.82% and the 5 year cagr is -2.00%. Total return includes dividends reinvested.

The closing share price for Danaher Corporation (DHR) stock was $188.41 for Tuesday, June 9, 2026, up +2.66% from the previous day.

DHR Price Chart

End-of-day pricesAdvanced chart →
DHR$188.41 -3.75%as of Jun 9, 2026

DHR Earnings Preview

Next Earnings Date

Jul 21, 2026

42 days away

EPS Estimate

1.83

Revenue Est.

$6.09B

Last Quarter Results

EPS

$2.06

vs Estimate

$1.94

Beat

Revenue

$5.95B

vs Estimate

$5.98B

Met

DHR Analyst Ratings

Consensus Rating

Buy

Based on 22 analysts

Strong Buy
4
Buy
18
Hold
3
Sell
0
Strong Sell
0

Average Price Target

$244.27

+29.6% upside

Low

$200.00

Current

$188.41

High

$310.00

DHR Analyst Estimates

Forward P/E: 20.70

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2027N/A$2.16N/A6
Q2 2027N/A$2.03N/A12
Q3 2027N/A$2.19N/A6
Q4 2027N/A$2.68N/A10

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$9.10N/A14
FY 2028N/A$9.96N/A5

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2027N/A$6.33BN/A6
Q2 2027N/A$6.50BN/A12
Q3 2027N/A$6.65BN/A6
Q4 2027N/A$7.59BN/A10

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$27.06BN/A14
FY 2028N/A$28.91BN/A5

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

DHR Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGR
1DHR$133.37B$188.41+2.66%-4.76%-2.00%+14.71%

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair